Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Ajanta Pharma Gets Relief in Erectile Dysfunction Drug Export Case, Penalty Set Aside

Ajanta Pharma to add liquid formulation facility at Pithampur site

Ruchika Sharma22 March 2025 2:45 PM IST

Mumbai: Ajanta Pharma has announced an expansion of its manufacturing capabilities by adding a state-of-the-art liquid formulation facility at...

Shilpa Medicare Dabaspet unit gets VAI classification from USFDA

Alembic Pharma Karakhadi facility successfully completes USFDA inspection

Ruchika Sharma22 March 2025 11:30 AM IST

Vadodara: Alembic Pharma has announced that the Company has successfully completed the United States Food and Drug Administration (USFDA) inspection...

Morepen Labs incorporates new step-down subsidiary in mainland Dubai

Ministry of Corporate Affairs approves incorporation of Quick Med: Morepen Labs

Ruchika Sharma21 March 2025 5:06 PM IST

Haryana: Morepen Labs has announced that the Ministry of Corporate Affairs has approved the incorporation of 'QUICK MED PRIVATE LIMITED'. ...

Piramal Pharma arm, BrePco Biopharma get UKMHRA approval for Neoatricon in UK

Ruchika Sharma21 March 2025 3:30 PM IST

Dublin: BrePco Biopharma Limited (BPCO) that develops products for the unique needs of paediatric patients and Piramal Critical Care...

Lupin awarded EcoVadis Silver Medal for sustainability excellence

Ruchika Sharma21 March 2025 2:30 PM IST

Mumbai: Global pharma major Lupin Limited has announced that it has been awarded "Silver Medal" by EcoVadis for its outstanding sustainability...

Bharat Biotech unveils vertically integrated cell, gene therapy, viral production facility at Genome Valley

Ruchika Sharma21 March 2025 1:30 PM IST

Hyderabad: Bharat Biotech International Limited (BBIL), has announced the launch of India's only vertically integrated, purpose-designed Cell &...

Novartis oral Fabhalta gets USFDA nod for adults with C3 glomerulopathy

Novartis oral Fabhalta secures USFDA okay for adults with C3 glomerulopathy

Ruchika Sharma21 March 2025 12:42 PM IST

Basel: Novartis has announced that the U.S. Food and Drug Administration (FDA) has approved oral Fabhalta (iptacopan) for the treatment...

USFDA nod to JnJ Tremfya for Crohn's disease

Ruchika Sharma21 March 2025 10:30 AM IST

Horsham: Johnson & Johnson has announced that the Company ahs received approval from the U.S. Food and Drug Administration (FDA) for TREMFYA...

Himachal to develop medical device park independently

Prioritize healthcare security through balanced tariff measures for medical devices: AiMeD urges Govt

Ruchika Sharma20 March 2025 5:30 PM IST

Recall of Medtronic embolization devices classified as most serious by USFDA

Ruchika Sharma20 March 2025 4:45 PM IST

Medtronic's recall of embolization device has been classified most serious by the U.S. Food and Drug Administration (USFDA), citing potential risks of...

Natco Pharma gets 7 USFDA observations for Kothur Pharma Division

Aurobindo Pharma arm gets USFDA EIR for Telangana unit

Ruchika Sharma20 March 2025 3:30 PM IST

Telangana: Apitoria Pharma Private Limited, a wholly owned subsidiary of Aurobindo Pharma, has received an Establishment Inspection Report...

Syngene acquires biologics site from Emergent BioSolutions arm for USD 36.5 million

Syngene concludes acquisition of biologics manufacturing facility from Emergent BioSolutions

Ruchika Sharma20 March 2025 2:30 PM IST

Bengaluru: Syngene International Limited has announced the conclusion of the acquisition of its first biologics site in the USA, which was announced...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok